Testing effectiveness (Phase 2)Study completedNCT00274781
What this trial is testing
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Who this might be right for
LeukemiaMyelodysplastic Syndromes
The Cleveland Clinic 30